Twin Tree Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Twin Tree Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-92,100	Closed	-$9.69M	–	1948
2022 Q1	$9.69M	Buy	+92,100	New	+$8.98M	0.02%	705
2021 Q4	–	Sell	-21,500	Closed	-$2.35M	–	1921
2021 Q3	$2.35M	Buy	+21,500	New	+$2.23M	0.01%	989
2021 Q2	–	Sell	-4,900	Closed	-$451K	–	1695
2021 Q1	$451K	Buy	+4,900	New	+$414K	﹤0.01%	1075
2020 Q3	–	Sell	-44,800	Closed	-$2.49M	–	1702
2020 Q2	$2.49M	Buy	44,800 +38,600	+623%	+$1.65M	0.01%	828
2020 Q1	$184K	Sell	6,200 -33,500	-84%	-$1.13M	﹤0.01%	1066
2019 Q4	$1.44M	Buy	+39,700	New	+$1.22M	0.01%	791

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Twin Tree Management's HZNP Position: Q1 2023 in Review

Twin Tree Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 183,077 shares — an estimated $20.8M sold.

Twin Tree Management first reported a position in HZNP in Q1 2019 and held it in 10 quarters. The position peaked at $20.8M in Q4 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Twin Tree Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Twin Tree Management sold 183,077 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $20.8M.
Twin Tree Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 10 quarters.
Twin Tree Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $20.8M in Q4 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Twin Tree Management's 13F filing for Q1 2023, filed 10 May 2023.